# Survival Rate After TheraCal PT Pulpotomy Versus MTA Pulpotomy in Children With Vital Primary Molars.

> **NCT04617600** · NA · UNKNOWN · sponsor: **Cairo University** · enrollment: 20 (estimated)

## Conditions studied

- Reversible Pulpitis

## Interventions

- **DRUG:** MTA
- **DRUG:** TheraCal PT

## Key facts

- **NCT ID:** NCT04617600
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-03-01
- **Primary completion:** 2022-06-01
- **Final completion:** 2022-11-01
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2022-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04617600

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04617600, "Survival Rate After TheraCal PT Pulpotomy Versus MTA Pulpotomy in Children With Vital Primary Molars.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04617600. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*